Dates: June 27 (Wed) – 29(Fri), 2018
Venue: Tokyo Big Sight  Organised by: Reed Exhibitions Japan Ltd.
*Be sure to make appointments with pharmaceutical
  company sponsors before the show.

* Contact information is open to public for the purpose of visitors to request appointments before the show.
Unauthorized sales activities a/o inappropriate activities toward exhibitors are strictly prohibited.

Technologies in Search
EA Pharmaceuticals is new integrated company of Gastrointestinal Division of Eisai and Ajinomoto Pharmaceuticals which was 100% subsidiary of Ajinomoto Co., Inc. and establishes on 1st April, 2016. EA Pharmaceuticals responsible for gastrointestinal disease business in Eisai Group. We have business mainly in Japan and are extending them in East Asia region. Our R&D focuses on GI (especially IBD), liver diseases and pancreatic diseases. We are seeking for in-license opportunities in those spaces and also looking for in-license items of unexplored field with high unmet medical needs.
Target Field of Research, Disease, Pipelines
Any (no specific disease) Dermatological Disease Infectious Disease, Virus Disease
Cancer Dental, Oral Disease Cardiovascular Disease
Kidney/Renal Disease Cardiovascular Disease Adult/Lifestyle-related Diseases
Ophthalmic Disease Neurological Disease Regenerative Medicine
Liver Disease Respiratory Disease Senescence, Anti-aging
Obstetrical, Urological Disease Metabolic Disease Others
Gastrointestinal Disease
Inflammatory, Immunological Disease